These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3054231)

  • 41. Hypertension in chronic renal failure.
    Vertolli U
    Nephron; 1991; 58(3):371. PubMed ID: 1896106
    [No Abstract]   [Full Text] [Related]  

  • 42. Angiotensin converting enzyme (ACE) inhibitors and renal function. A review of the current status.
    Kamper AL
    Drug Saf; 1991; 6(5):361-70. PubMed ID: 1930742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Captopril--an inhibitor of the angiotensin I converting enzyme--in the treatment of arterial hypertension in chronic kidney failure patients].
    Manasia M; Paţiu IM; Vlăduţiu D; Madi A; Barabas E; Gherman M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(3):217-22. PubMed ID: 2865784
    [No Abstract]   [Full Text] [Related]  

  • 44. Primary hyperaldosteronism in a patient with end-stage renal disease.
    Kazory A; Weiner ID
    Nephrol Dial Transplant; 2007 Mar; 22(3):917-9. PubMed ID: 17127694
    [No Abstract]   [Full Text] [Related]  

  • 45. [Converting enzyme inhibitors in preterminal renal failure].
    Rambausek MH; Ritz E
    Dtsch Med Wochenschr; 1992 Jan; 117(2):77. PubMed ID: 1730207
    [No Abstract]   [Full Text] [Related]  

  • 46. [Administration of captopril (aceten++, ++"Vokhardt"++) in hypertension and congestive heart failure].
    Balakhonova NP; Avdeev VG; Kuznetsov NE; Liapon DO; Senchikhin PV
    Klin Med (Mosk); 1997; 75(1):42-3. PubMed ID: 9082059
    [No Abstract]   [Full Text] [Related]  

  • 47. Hypertension in end-stage renal disease: target values, methods of measurement and drug therapy.
    Zoccali C
    J Nephrol; 2002; 15(2):199-201. PubMed ID: 12018640
    [No Abstract]   [Full Text] [Related]  

  • 48. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
    Palmer BF
    Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictability of a standardized captopril-test in hypertension in end-stage renal failure.
    Schohn DC; Jahn HA; Schmitt RL
    Kidney Int Suppl; 1988 Sep; 25():S145-8. PubMed ID: 3054231
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.